Northwestern Mutual Wealth Management
CHRS icon

Northwestern Mutual Wealth Management’s Coherus Oncology CHRS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
7,350
– – ﹤0.01% 3108
2026
Q1 		$12.4K Hold
7,350
– – ﹤0.01% 2993
2025
Q4 		$10.4K Hold
7,350
– – ﹤0.01% 2973
2025
Q3 		$12.1K Sell
7,350
-35
-0.5% -$39 ﹤0.01% 2845
2025
Q2 		$5.4K Sell
7,385
-2,465
-25% -$2.13K ﹤0.01% 2988
2025
Q1 		$7.95K Buy
9,850
+2,500
+34% +$2.88K ﹤0.01% 2817
2024
Q4 		$10.1K Hold
7,350
– – ﹤0.01% 2736
2024
Q3 		$7.64K Hold
7,350
– – ﹤0.01% 2779
2024
Q2 		$12.7K Hold
7,350
– – ﹤0.01% 2558
2024
Q1 		$17.6K Buy
+7,350
New +$18.1K ﹤0.01% 2456
2022
Q1 		– Sell
-17
Closed – – 3136
2021
Q4 		$0 Buy
+17
New +$297 ﹤0.01% 3157
2020
Q1 		– Sell
-6
Closed – – 2575
2019
Q4 		$0 Buy
+6
New +$111 ﹤0.01% 2410

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Northwestern Mutual Wealth Management's CHRS Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Coherus Oncology (CHRS) position steady in Q2 2026 at 7,350 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

Northwestern Mutual Wealth Management first reported a position in CHRS in Q4 2019 and has held it in 12 quarters since. The position peaked at $17.6K in Q1 2024. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Northwestern Mutual Wealth Management held 7,350 shares of Coherus Oncology worth $10.3K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3108 holding.
  • Northwestern Mutual Wealth Management first reported a position in Coherus Oncology in Q4 2019 and has held it in 12 quarters since.
  • Northwestern Mutual Wealth Management's Coherus Oncology position peaked at $17.6K in Q1 2024.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.